Marco Donia, Professor at University of Copenhagen, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“The science of tumor-infiltrating lymphocytes (TIL),
Pleasure to contribute to this collaborative effort, disentangling the complexity of the only polyclonal, Cell Therapy approved for the treatment of Cancer
Thanks to all contributors, in particular to George Coukos and Michael Lotze for leading this work!”
Title: The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
Authors: George Coukos, Marco Donia, Brian R Gastman, Stephanie L Goff, Alena Gros, Alexandre Harari, Sophia Hernandez, Fumito Ito, Ajay V Maker, John E Mullinax, Pranav Murthy, Sara I Pai, Sangeetha Prabhakaran, Nicholas P Restifo, Natalie L Silver, Paula Marincola Smith, Simon Turcotte, Patrick L Wagner, James C Yang, Michael T Lotze
Read the Full Article on Journal for ImmunoTherapy of Cancer
More posts featuring Marco Donia.